Zobrazeno 1 - 10
of 112
pro vyhledávání: '"G O Barbezat"'
Publikováno v:
Digestive Diseases and Sciences. 46:2499-2503
Somatostatin inhibits colonic ion secretion in animal models and cultured intestinal cell lines via somatostatin receptor subtype 2 and subtype 1, respectively. In a recent in vitro ion transport study of the human colon, somatostatin was shown to st
Publikováno v:
Digestive Diseases and Sciences. 45:2100-2107
In vitro somatostatin is a potent inhibitor of intestinal ion secretion in animal models and cultured human cell lines, providing a rationale for its use in secretory diarrheas. However, the effects of somatostatin on ion transport in native human co
Autor:
N. B. Higgs, I. Ross, M. J. M. Lewin, D. H. Coy, M. R. Grigor, G. O. Barbezat, F. Reyl-Desmars, G. Warhurst
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 269:G729-G736
Recent studies in a cultured model of the intestinal epithelium (HT-29cl.19A) have shown that somatostatin-14 (SS-14) inhibits the Cl- secretory process by acting at multiple G protein-dependent sites. These actions may underlie the antidiarrheal pro
Publikováno v:
Gut. 32:1117-1120
Pharmacological doses of atrial natriuretic peptide were infused into rats to study its effect on intestinal transport. Saline control or two concentrations of rat alpha atrial natriuretic peptide (0.06 or 1.0 nmol/min/kg) were administered intraveno
Publikováno v:
Gut. 32:635-639
The effects of atrial natriuretic peptide were investigated on water and electrolyte transport in the human jejunum. Six healthy male volunteers (aged 21-33 years) were studied using a triple lumen perfusion technique. A plasma like electrolyte solut
Publikováno v:
Digestive diseases and sciences. 46(11)
Somatostatin inhibits colonic ion secretion in animal models and cultured intestinal cell lines via somatostatin receptor subtype 2 and subtype 1, respectively. In a recent in vitro ion transport study of the human colon, somatostatin was shown to st
Publikováno v:
Alimentary pharmacologytherapeutics. 13(8)
Better control of gastric acid secretion with omeprazole appeared to decrease the need for dilatation of oesophageal strictures complicating gastro-oesophageal reflux disease in our hospital-based endoscopy service.To investigate whether the perceive
Autor:
G O, Barbezat
Publikováno v:
The Medical journal of Australia. 170(8)
Publikováno v:
Australian and New Zealand journal of medicine. 28(5)
Background: Helicobacter pylori seroprevalence increases with age in adult life but spontaneous reversion may occur in childhood and adolescence. Aims: To determine the seroprevalence of H. pylori in a longitudinal study of New Zealanders at ages 11
Autor:
G O, Barbezat
Publikováno v:
British journal of hospital medicine. 54(11)
This article summarises the current position concerning the pathogenesis, clinical picture, diagnosis and management of reflux oesophagitis. It is aimed at the practising clinician who forms part of the team including primary care and specialist-base